approval · primary record
DILTIAZEM HYDROCHLORIDE
FDA · NDA · 2025-02-21
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2025-02-21 |
| Brand | DILTIAZEM HYDROCHLORIDE IN 0.72% SODIUM CHLORIDE |
| Sponsor | HQ SPCLT PHARMA |
| Route | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:40.599Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:DILTIAZEM HYDROCHLORIDE:2025-02-21
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.